GlaxoSmithKline and MedTrust Online Team to Provide Cancer Doctors Better Mobile Access to Cancer Clinical Trials

SCOTTSDALE, Ariz. and RESEARCH TRIANGLE PARK, N.C., June 4 /PRNewswire/ -- GlaxoSmithKline, PLC and MedTrust Online, LLC announced today the development of CancerTrials App, the first free geolocating cancer clinical trials application for the Apple iPhone and iPad platforms.

With CancerTrials App, cancer doctors can easily find and share information about experimental therapies in clinical trials with their patients.  CancerTrials App provides a quick search menu based on 12 common cancers and more advanced features that refine searches based on criteria such as gender, age, trial status and more.  Once relevant trials are found, results can be mapped relative to the location of the iPhone or iPad running the application.

"GSK Oncology has always been interested in providing doctors and their patients with the access to the right information about the best therapies that improve patient outcomes," stated Jeffrey Bloss, M.D., Vice President, Medicine Development Leader for GSK Oncology.  "We are pleased to work with MedTrust Online to bring simple yet highly effective information-based solutions to the cancer community."

"Our community of oncologists continues to ask for information about the latest therapies in a format that fits their busy schedule," said Dr. Leo Otake, M.D., Ph.D., Vice President of Medical Informatics for MedTrust Online.  "This joint development with GSK Oncology has resulted in yet another effective electronic tool that empowers our users and brings cancer doctors closer to their patients."

CancerTrials App is the first release of a mobile application for several platforms that connects to MedTrust Online's proprietary databases of oncology information at www.oncocentric.com.  Solutions for RIM's BlackBerry and Google's Android operating systems will be released over the next several months.  Oncologists using mobile communication devices will be able to share more with their patients as they search for the best therapies available in their communities.

About MedTrust Online, LLC

MedTrust Online LLC, www.medtrust-online.com, provides oncologists with clinically useful technology applications and solutions. MedTrust Online brings together experts in oncology, information technology, computational biology, pharmaceutical drug development, and personalized medicine to capture, organize, analyze, integrate and present the most up-to-date medical facts from a vast array of sources. This data is provided to doctors in a comprehensive yet concise way at www.oncocentric.com.

About GlaxoSmithKline, PLC

GSK Oncology is dedicated to producing innovations in cancer that will make profound differences in the lives of patients. Through GSK's revolutionary 'bench to bedside' approach, we are transforming the way treatments are discovered and developed, resulting in one of the most robust pipelines in the oncology sector. Our worldwide research in oncology includes collaborations with more than 160 cancer centres. GSK is closing in on cancer from all sides with a new generation of patient-focused cancer treatments in prevention, supportive care, chemotherapy and targeted therapies.

GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

SOURCE MedTrust Online LLC